Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING DIABETES AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/232740
Kind Code:
A1
Abstract:
A pharmaceutical composition for preventing diabetes comprises: cannabidiol and/or a pharmaceutically acceptable salt or ester thereof; and one or more hypoglycemic agents. Optionally, the pharmaceutical composition further comprises one or more pharmaceutically acceptable excipients. The pharmaceutical composition can effectively decrease blood sugar, and significantly mitigate an adverse reaction induced by metformin or sulfonylurea secretagogues.

Inventors:
ZHANG KE (CN)
TAN XIN (CN)
YU ZHAOHUI (CN)
LI XIANGDONG (CN)
LIAN MENG (CN)
Application Number:
PCT/CN2018/090226
Publication Date:
December 12, 2019
Filing Date:
June 07, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANYI BIO TECH COMPANY LTD (CN)
International Classes:
A61K31/05; A61K31/155; A61K31/64; A61P3/06; A61P3/10
Domestic Patent References:
WO2016181394A12016-11-17
WO2007138322A12007-12-06
WO2005077348A12005-08-25
Foreign References:
CN101977596A2011-02-16
CN106943373A2017-07-14
CN103945841A2014-07-23
Other References:
"Guidelines for the Prevention and Treatment of Type 2 Diabetes in China", 2017
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: